AU Patent

AU2004285924B2 — Hydrochloride salts of a glycopeptide phosphonate derivative

Assigned to Cumberland Pharmaceuticals Inc · Expires 2011-02-24 · 15y expired

What this patent protects

Patent listed against Vibativ.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004285924B2
Jurisdiction
AU
Classification
—
Expires
2011-02-24
Drug substance claim
No
Drug product claim
No
Assignee
Cumberland Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.